Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Coombes RC., Howell S., Lord SR., Kenny L., Mansi J., Mitri Z., Palmieri C., Chap LI., Richards P., Gradishar W., Sardesai S., Melear J., O'Shaughnessy J., Ward P., Chalasani P., Arkenau T., Baird RD., Jeselsohn R., Ali S., Clack G., Bahl A., McIntosh S., Krebs MG.

DOI

10.1038/s41467-025-57535-w

Type

Journal article

Journal

Nat Commun

Publication Date

06/03/2025

Volume

16

Permalink Original publication